411 related articles for article (PubMed ID: 27213837)
1. Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw?
Klingelhöffer C; Klingelhöffer M; Müller S; Ettl T; Wahlmann U
Dentomaxillofac Radiol; 2016; 45(5):20160065. PubMed ID: 27213837
[TBL] [Abstract][Full Text] [Related]
2. Comparison of findings of radiographic and fractal dimension analyses on panoramic radiographs of patients with early-stage and advanced-stage medication-related osteonecrosis of the jaw.
Şahin O; Odabaşı O; Demiralp KÖ; Kurşun-Çakmak EŞ; Aliyev T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Jul; 128(1):78-86. PubMed ID: 31005615
[TBL] [Abstract][Full Text] [Related]
3. Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure.
Hutchinson M; O'Ryan F; Chavez V; Lathon PV; Sanchez G; Hatcher DC; Indresano AT; Lo JC
J Oral Maxillofac Surg; 2010 Sep; 68(9):2232-40. PubMed ID: 20728032
[TBL] [Abstract][Full Text] [Related]
4. Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer.
Bianchi SD; Scoletta M; Cassione FB; Migliaretti G; Mozzati M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):249-58. PubMed ID: 17560140
[TBL] [Abstract][Full Text] [Related]
5. Dental panoramic radiographic evaluation in bisphosphonate-associated osteonecrosis of the jaws.
Treister N; Sheehy N; Bae EH; Friedland B; Lerman M; Woo S
Oral Dis; 2009 Jan; 15(1):88-92. PubMed ID: 18992020
[TBL] [Abstract][Full Text] [Related]
6. Local radiographic risk factors for MRONJ in osteoporotic patients undergoing tooth extraction.
Moreno-Rabié C; Gaêta-Araujo H; Ferreira-Leite A; Coucke W; Gielen E; Van den Wyngaert T; Jacobs R
Oral Dis; 2024 Apr; 30(3):1632-1642. PubMed ID: 36620873
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate and Medication-Related Osteonecrosis of the Jaw: A Review.
Mücke T; Krestan CR; Mitchell DA; Kirschke JS; Wutzl A
Semin Musculoskelet Radiol; 2016 Jul; 20(3):305-314. PubMed ID: 27741546
[TBL] [Abstract][Full Text] [Related]
8. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
Dodson TB
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
[TBL] [Abstract][Full Text] [Related]
9. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
[TBL] [Abstract][Full Text] [Related]
10. Imaging findings in bisphosphonate-related osteonecrosis of jaws.
Arce K; Assael LA; Weissman JL; Markiewicz MR
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):75-84. PubMed ID: 19371818
[TBL] [Abstract][Full Text] [Related]
11. "Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review.
Khominsky A; Lim M
Aust Dent J; 2018 Dec; 63(4):441-454. PubMed ID: 30144095
[TBL] [Abstract][Full Text] [Related]
12. Why do some extraction sites develop medication-related osteonecrosis of the jaw and others do not? A within-patient study assessing radiographic predictors.
Gaêta-Araujo H; Ferreira Leite A; de Faria Vasconcelos K; Coropciuc R; Politis C; Jacobs R; Oliveira-Santos C
Int J Oral Implantol (Berl); 2021 Mar; 14(1):87-98. PubMed ID: 34006074
[TBL] [Abstract][Full Text] [Related]
13. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
[TBL] [Abstract][Full Text] [Related]
14. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
Ristow O; Rückschloß T; Müller M; Berger M; Kargus S; Pautke C; Engel M; Hoffmann J; Freudlsperger C
J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study.
Kajizono M; Sada H; Sugiura Y; Soga Y; Kitamura Y; Matsuoka J; Sendo T
Biol Pharm Bull; 2015; 38(12):1850-5. PubMed ID: 26632176
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
Ruggiero SL
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329
[TBL] [Abstract][Full Text] [Related]
17. Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw.
Obermeier KT; Dewenter I; Malenova Y; Fliefel R; Kaeppler G; Otto S
Sci Rep; 2024 Apr; 14(1):7914. PubMed ID: 38575664
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional clinical assessment for MRONJ risk in oncologic patients following tooth extractions.
Moreno Rabie C; Cavalcante Fontenele R; Oliveira Santos N; Nogueira Reis F; Van den Wyngaert T; Jacobs R
Dentomaxillofac Radiol; 2023 Nov; 52(8):20230238. PubMed ID: 37874081
[TBL] [Abstract][Full Text] [Related]
19. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
[TBL] [Abstract][Full Text] [Related]
20. Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review.
Wongratwanich P; Shimabukuro K; Konishi M; Nagasaki T; Ohtsuka M; Suei Y; Nakamoto T; Verdonschot RG; Kanesaki T; Sutthiprapaporn P; Kakimoto N
Dentomaxillofac Radiol; 2021 Sep; 50(6):20200417. PubMed ID: 33411572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]